欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号CZ/V/0136/001
药品名称BioBos Respi 2 intranasal, nasal spray, lyophilisate and solvent for suspension
活性成分
    • Bovine parainfluenza 3 virus attenuated 10.5 TCID50/dose
    • bovine respiratory syncytial virus 10.4 TCID50/dose
剂型Lyophilisate and Solvent
上市许可持有人Bioveta, a.s. Komenského 212/12 683 23 Ivanovice na Hané Czech Republic Tel.: 00 420 517 318 502 Fax: 00 420 517 318 653 Email: linhart.jakub@bioveta.cz
参考成员国 - 产品名称Czechia (CZ)
BioBos Respi 2 intranasal, nosní sprej, lyofilizát a rozpouštědlo pro suspenzi
互认成员国 - 产品名称
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
      BioBos Respi 2 intranasal
    • Hungary (HU)
      BioBos Respi 2 intranasal vakcina A.U.V.
    • Bulgaria (BG)
    • Cyprus (CY)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2016/12/21
最近更新日期2025/08/19
药物ATC编码
    • QI02AD07 bovine respiratory syncytial virus + bovine parainfluenza virus
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase